200 related articles for article (PubMed ID: 24890254)
1. A systematic review and meta-analysis of gastric cancer treatment in patients with positive peritoneal cytology.
Cabalag CS; Chan ST; Kaneko Y; Duong CP
Gastric Cancer; 2015 Jan; 18(1):11-22. PubMed ID: 24890254
[TBL] [Abstract][Full Text] [Related]
2. The Importance of Extensive Intraoperative Peritoneal Lavage as a Promising Method in Patients with Gastric Cancer Showing Positive Peritoneal Cytology Without Overt Peritoneal Metastasis and Other Therapeutic Approaches.
Ilhan E; Alemdar A; Ureyen O; Bas K
J Invest Surg; 2017 Oct; 30(5):318-324. PubMed ID: 27806214
[TBL] [Abstract][Full Text] [Related]
3. [Peritoneal lavage cytology under local anesthesia for detection of peritoneal recurrence after surgery].
Okada K; Fujiwara Y; Takahashi T; Kurokawa Y; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2363-5. PubMed ID: 22202383
[TBL] [Abstract][Full Text] [Related]
4. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
[TBL] [Abstract][Full Text] [Related]
5. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma.
Kuramoto M; Shimada S; Ikeshima S; Matsuo A; Yagi Y; Matsuda M; Yonemura Y; Baba H
Ann Surg; 2009 Aug; 250(2):242-6. PubMed ID: 19638909
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.
Yamaguchi T; Takashima A; Nagashima K; Makuuchi R; Aizawa M; Ohashi M; Tashiro K; Yamada T; Kinoshita T; Hata H; Kawachi Y; Kawabata R; Tsuji T; Hihara J; Sakamoto T; Fukagawa T; Katai H; Higuchi K; Boku N
Ann Surg Oncol; 2020 Jan; 27(1):284-292. PubMed ID: 31535301
[TBL] [Abstract][Full Text] [Related]
8. [Clinical trials of neo-adjuvant chemotherapy for advanced gastric cancer with peritoneal dissemination].
Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamazaki M; Nishida T; Doki Y
Gan To Kagaku Ryoho; 2008 Nov; 35(12):1996-8. PubMed ID: 19106502
[TBL] [Abstract][Full Text] [Related]
9. [The future of loco-regional treatment for advanced gastric cancer].
Nagahama T; Ando M; Ganno H; Ami K; Fukuda A; Maruyama M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2012-4. PubMed ID: 19106507
[TBL] [Abstract][Full Text] [Related]
10. Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis.
Nakayama I; Chin K; Matsushima T; Takahari D; Ogura M; Shinozaki E; Suenaga M; Ozaka M; Wakatsuki T; Ichimura T; Hiroki O; Yamaguchi K
Int J Clin Oncol; 2017 Dec; 22(6):1060-1068. PubMed ID: 28748355
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal Lavage CEA mRNA Levels Predict Conversion Gastrectomy Outcomes after Induction Chemotherapy with Intraperitoneal Paclitaxel in Gastric Cancer Patients with Peritoneal Metastasis.
Yamaguchi H; Satoh Y; Ishigami H; Kurihara M; Yatomi Y; Kitayama J
Ann Surg Oncol; 2017 Oct; 24(11):3345-3352. PubMed ID: 28726078
[TBL] [Abstract][Full Text] [Related]
12. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
[TBL] [Abstract][Full Text] [Related]
13. Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial.
Ito S; Ohashi Y; Sasako M
BMC Cancer; 2018 Apr; 18(1):449. PubMed ID: 29678146
[TBL] [Abstract][Full Text] [Related]
14. [Treatment for advanced gastric cancer with positive lavage cytology-systemic versus intraperitoneal chemotherapy].
Iwasaki Y; Ohashi M; Nunobe S; Iwanaga T; Iwagami S; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2009-11. PubMed ID: 19106506
[TBL] [Abstract][Full Text] [Related]
15. Extended intraoperative peritoneal lavage as prophylactic peritoneal recurrence for locally advanced gastric cancer: a prospective randomized trial.
Rodríguez-Santiago J; Luna A; Garsot E; Aldeano A; Balagué C; Rada A
Clin Transl Oncol; 2021 Sep; 23(9):1857-1865. PubMed ID: 33792839
[TBL] [Abstract][Full Text] [Related]
16. Effect of intraperitoneal chemotherapy and peritoneal lavage in positive peritoneal cytology in gastric cancer. Systematic review and meta-analysis.
Coccolini F; Catena F; Glehen O; Yonemura Y; Sugarbaker PH; Piso P; Ceresoli M; Montori G; Ansaloni L
Eur J Surg Oncol; 2016 Sep; 42(9):1261-7. PubMed ID: 27134147
[TBL] [Abstract][Full Text] [Related]
17. Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial).
Misawa K; Mochizuki Y; Sakai M; Teramoto H; Morimoto D; Nakayama H; Tanaka N; Matsui T; Ito Y; Ito S; Tanaka K; Uemura K; Morita S; Kodera Y;
Br J Surg; 2019 Nov; 106(12):1602-1610. PubMed ID: 31573086
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Extensive Intraperitoneal Lavage for Patients with Gastric Cancer - A Systematic Review and Meta-analysis.
Najah Q; Abdelrehim AM; Elmallahy M; Alsubayhay A; Alabdallat YJ
J Gastrointest Cancer; 2024 Mar; 55(1):96-104. PubMed ID: 37750984
[TBL] [Abstract][Full Text] [Related]
19. [A case report of the combination therapy with S-1 plus CDDP intraperitoneal chemotherapy for CY positive cancer patient].
Ishii Y; Iwasaki Y; Ohashi M; Iwanaga T; Ohinata R; Takahashi K; Matsumoto H; Yamaguchi T; Nakano D
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2084-6. PubMed ID: 22202291
[TBL] [Abstract][Full Text] [Related]
20. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.
Canbay E; Mizumoto A; Ichinose M; Ishibashi H; Sako S; Hirano M; Takao N; Yonemura Y
Ann Surg Oncol; 2014 Apr; 21(4):1147-52. PubMed ID: 24356799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
